Does TROFOSFAMIDE Cause Product use in unapproved indication? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Product use in unapproved indication have been filed in association with TROFOSFAMIDE. This represents 14.7% of all adverse event reports for TROFOSFAMIDE.
16
Reports of Product use in unapproved indication with TROFOSFAMIDE
14.7%
of all TROFOSFAMIDE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Product use in unapproved indication From TROFOSFAMIDE?
Of the 16 reports, 2 (12.5%) required hospitalization.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TROFOSFAMIDE. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does TROFOSFAMIDE Cause?
Acute myeloid leukaemia (18)
Myelodysplastic syndrome (18)
Off label use (15)
Neutropenia (14)
Anaemia (13)
Dyspnoea (12)
Oedema (10)
Pleural effusion (10)
Hepatosplenomegaly (9)
Hyperleukocytosis (9)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which TROFOSFAMIDE Alternatives Have Lower Product use in unapproved indication Risk?
TROFOSFAMIDE vs TROPATEPINE
TROFOSFAMIDE vs TROPICAMIDE
TROFOSFAMIDE vs TROSPIUM
TROFOSFAMIDE vs TROSPIUM\XANOMELINE
TROFOSFAMIDE vs TRUVADA